Fischer Medical Ventures Limited has scheduled a meeting with analysts and investors on September 7, 2026. The company disclosed the agenda via an exchange filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting details

The engagement is designed to update stakeholders on the company's strategic direction. Fischer Medical Ventures described itself as building the world's largest Healthcare AI Solutions Platform, focusing on AI-enabled medical imaging, population-scale screening, and hospital digitization.

Strategic ecosystem

The presentation highlighted an integrated ecosystem comprising three operating brands:

• Time Medical: Provides the technology foundation with advanced MRI and diagnostic equipment.
• FMV: Acts as the commercialization and capital vehicle, integrating diagnostics, AI, and biologics.
• FlynnCare: Develops AI healthcare applications, including the MIDAS screening ecosystem.

This structure aims to converge technology, commercialization, and AI applications into a single integrated healthcare innovation engine.

Product portfolio

The company outlined its key product verticals:

Medical Imaging

Time Medical offers a full-spectrum MRI portfolio ranging from 0.35T open systems (PICA, AURA) to 7.0T ultra-high field research platforms (Nova 7T). The range includes helium-free magnets and closed-bore systems like the MICA and QUIN series. The company also listed CT imaging solutions (Clarion series) and portable X-ray devices as part of its diagnostic offerings.

AI & Digital Health

FlynnCare's MIDAS platform enables multi-disciplinary early disease detection across eye, oral, mental, and cardiovascular health. The LIVE Dx platform supports population-scale screening with tele-health integration. Additionally, the Clinics 2.0 platform provides EHR, HIS, and practice management solutions.

Biologics & Other Ventures

Nanyang Biologics focuses on AI-driven drug discovery using NVIDIA and HPE infrastructure, with partnerships involving Johnson & Johnson Innovation JLABS. The company also mentioned SpinCare regenerative skin technology and Obelab brain imaging platforms.

Fischer Medical Ventures has entered the advanced diagnostic imaging segment through its wholly owned subsidiary, Time Medical International Ventures (India) Private Ltd. The launch of the CLARION 64/128-Slice AI-Driven CT System at the India Health Expo 2026 marks a strategic expansion into high-performance medical hardware.

The event was formally inaugurated by Dr. Sunil K. Khetrapal, Deputy Director General of the Association of Healthcare Providers India (AHPI). The presence of senior healthcare administrators signals industry validation for the platform’s focus on intelligent clinical workflows and sustainable healthcare delivery.

Product Specifications

The CLARION platform integrates high-performance imaging hardware with artificial intelligence to support diagnostic precision and operational efficiency. Key technical features include:

Clinical Configurations

The system is available in scalable configurations tailored to specific clinical requirements:

• 64-Slice Configuration: Features a 91 cm bore, suitable for vascular imaging and intraoperative applications.
• 128-Slice Configuration: Supports advanced procedures requiring higher temporal resolution, including cardiac, neurological, and thoracic imaging.

Interventional Capabilities

Beyond conventional diagnostics, the CLARION platform extends into interventional and surgical environments. The Big Bore CT-on-Rail configuration enables mobility between clinical scenarios and supports hybrid operating room integration. Advanced capabilities such as 4D CT phased acquisition assist in respiratory monitoring and tumor targeting during radiotherapy by reducing motion-related artifacts.

Strategic Context

Time Medical International Ventures specializes in the design and manufacture of high-performance MRI systems. The introduction of the CLARION CT system reinforces the group’s commitment to building a comprehensive medical imaging ecosystem that combines engineering innovation with AI-driven workflows.